Normal view MARC view ISBD view

Preclinical Evaluation of Azadirachta Indica for Treatment of Polycystic Ovarian Syndrome with respect to PI3 Kinase Inhibition

By:

Material type: Text

TextPublication details: Ahmedabad Institute of Pharmacy, Nirma University 2016Description: 101pDDC classification:

Online resources:

Tags from this library: No tags from this library for this title. Log in to add tags.

Average rating: 0.0 (0 votes)

Holdings
Item type	Current library	Collection	Call number	Status	Date due	Barcode	Item holds
Dissertation	NIMA Knowledge Centre Reference	Reference	615.1 PAT (Browse shelf(Opens below))	Not For Loan		PDR00422
CD/DVD	NIMA Knowledge Centre Reference	Reference	615.1 PAT (Browse shelf(Opens below))	Not For Loan		PDR00422-1

Total holds: 0

Previous	No cover image available	No cover image available	No cover image available	No cover image available	No cover image available	No cover image available	No cover image available	Next
Previous	615.1 PAT Diabetic Retinopathy: A Comprehensive Review	615.1 PAT Determination of Risk Factors Prevalence in Western Region of India Contributing to Female Infertality	615.1 PAT Determination of Risk Factors Prevalence in Western Region of India Contributing to Female Infertality	615.1 PAT Preclinical Evaluation of Azadirachta Indica for Treatment of Polycystic Ovarian Syndrome with respect to PI3 Kinase Inhibition	615.1 PAT Preclinical Evaluation of Azadirachta Indica for Treatment of Polycystic Ovarian Syndrome with respect to PI3 Kinase Inhibition	615.1 PAT Formulation Development and Characterization of Osmotically Controlled Oral Drug Delivery System for Sparingly Water Soluble Drugs	615.1 PAT Formulation Development and Characterization of Osmotically Controlled Oral Drug Delivery System for Sparingly Water Soluble Drugs	Next

Guided by Dr. Snehal S. Patel

There are no comments on this title.

to post a comment.